Table of Content

1 Mental Disorders Drugs Market Overview
1.1 Mental Disorders Drugs Product Scope
1.2 Mental Disorders Drugs Segment by Type
1.2.1 Global Mental Disorders Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Drugs for Schizophrenia
1.2.3 Antidepressants
1.2.4 Antipsychotics
1.2.5 Anxiolytics
1.2.6 Drugs for the Treatment of Substance and Alcohol Addiction
1.2.7 Drugs for Childhood and Adolescent Mental Illness
1.2.8 Drugs to Treat Cognitive Disorders
1.2.9 Sleep Disorders
1.2.10 Others
1.3 Mental Disorders Drugs Segment by Application
1.3.1 Global Mental Disorders Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Children
1.3.3 Adolescents
1.3.4 Adults
1.4 Mental Disorders Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Mental Disorders Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Mental Disorders Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Mental Disorders Drugs Price Trends (2016-2027)

2 Mental Disorders Drugs Estimates and Forecasts by Region
2.1 Global Mental Disorders Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Mental Disorders Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Mental Disorders Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Mental Disorders Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Mental Disorders Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Mental Disorders Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Mental Disorders Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Mental Disorders Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Mental Disorders Drugs Estimates and Projections (2016-2027)
2.4.3 China Mental Disorders Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Mental Disorders Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Mental Disorders Drugs Estimates and Projections (2016-2027)
2.4.6 India Mental Disorders Drugs Estimates and Projections (2016-2027)

3 Global Mental Disorders Drugs Competition Landscape by Players
3.1 Global Top Mental Disorders Drugs Players by Sales (2016-2021)
3.2 Global Top Mental Disorders Drugs Players by Revenue (2016-2021)
3.3 Global Mental Disorders Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mental Disorders Drugs as of 2020)
3.4 Global Mental Disorders Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Mental Disorders Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Mental Disorders Drugs Market Size by Type
4.1 Global Mental Disorders Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Mental Disorders Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Mental Disorders Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Mental Disorders Drugs Price by Type (2016-2021)
4.2 Global Mental Disorders Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Mental Disorders Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Mental Disorders Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Mental Disorders Drugs Price Forecast by Type (2022-2027)

5 Global Mental Disorders Drugs Market Size by Application
5.1 Global Mental Disorders Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Mental Disorders Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Mental Disorders Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Mental Disorders Drugs Price by Application (2016-2021)
5.2 Global Mental Disorders Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Mental Disorders Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Mental Disorders Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Mental Disorders Drugs Price Forecast by Application (2022-2027)

6 North America Mental Disorders Drugs Market Facts & Figures
6.1 North America Mental Disorders Drugs Sales by Company
6.1.1 North America Mental Disorders Drugs Sales by Company (2016-2021)
6.1.2 North America Mental Disorders Drugs Revenue by Company (2016-2021)
6.2 North America Mental Disorders Drugs Sales Breakdown by Type
6.2.1 North America Mental Disorders Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Mental Disorders Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Mental Disorders Drugs Sales Breakdown by Application
6.3.1 North America Mental Disorders Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Mental Disorders Drugs Sales Breakdown by Application (2022-2027)

7 Europe Mental Disorders Drugs Market Facts & Figures
7.1 Europe Mental Disorders Drugs Sales by Company
7.1.1 Europe Mental Disorders Drugs Sales by Company (2016-2021)
7.1.2 Europe Mental Disorders Drugs Revenue by Company (2016-2021)
7.2 Europe Mental Disorders Drugs Sales Breakdown by Type
7.2.1 Europe Mental Disorders Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Mental Disorders Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Mental Disorders Drugs Sales Breakdown by Application
7.3.1 Europe 119 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 119 Sales Breakdown by Application (2022-2027)

8 China Mental Disorders Drugs Market Facts & Figures
8.1 China Mental Disorders Drugs Sales by Company
8.1.1 China Mental Disorders Drugs Sales by Company (2016-2021)
8.1.2 China Mental Disorders Drugs Revenue by Company (2016-2021)
8.2 China Mental Disorders Drugs Sales Breakdown by Type
8.2.1 China Mental Disorders Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Mental Disorders Drugs Sales Breakdown by Type (2022-2027)
8.3 China Mental Disorders Drugs Sales Breakdown by Application
8.3.1 China 144 Sales Breakdown by Application (2016-2021)
8.3.2 China 144 Sales Breakdown by Application (2022-2027)

9 Japan Mental Disorders Drugs Market Facts & Figures
9.1 Japan Mental Disorders Drugs Sales by Company
9.1.1 Japan Mental Disorders Drugs Sales by Company (2016-2021)
9.1.2 Japan Mental Disorders Drugs Revenue by Company (2016-2021)
9.2 Japan Mental Disorders Drugs Sales Breakdown by Type
9.2.1 Japan Mental Disorders Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Mental Disorders Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Mental Disorders Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Mental Disorders Drugs Market Facts & Figures
10.1 Southeast Asia Mental Disorders Drugs Sales by Company
10.1.1 Southeast Asia Mental Disorders Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Mental Disorders Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Mental Disorders Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Mental Disorders Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Mental Disorders Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Mental Disorders Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Mental Disorders Drugs Market Facts & Figures
11.1 India Mental Disorders Drugs Sales by Company
11.1.1 India Mental Disorders Drugs Sales by Company (2016-2021)
11.1.2 India Mental Disorders Drugs Revenue by Company (2016-2021)
11.2 India Mental Disorders Drugs Sales Breakdown by Type
11.2.1 India Mental Disorders Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Mental Disorders Drugs Sales Breakdown by Type (2022-2027)
11.3 India Mental Disorders Drugs Sales Breakdown by Application
11.3.1 India Mental Disorders Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Mental Disorders Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Mental Disorders Drugs Business
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Corporation Information
12.1.2 Johnson & Johnson Business Overview
12.1.3 Johnson & Johnson Mental Disorders Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Johnson & Johnson Mental Disorders Drugs Products Offered
12.1.5 Johnson & Johnson Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Business Overview
12.2.3 Pfizer Mental Disorders Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Mental Disorders Drugs Products Offered
12.2.5 Pfizer Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Corporation Information
12.3.2 Eli Lilly Business Overview
12.3.3 Eli Lilly Mental Disorders Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Eli Lilly Mental Disorders Drugs Products Offered
12.3.5 Eli Lilly Recent Development
12.4 GlaxoSmithKline
12.4.1 GlaxoSmithKline Corporation Information
12.4.2 GlaxoSmithKline Business Overview
12.4.3 GlaxoSmithKline Mental Disorders Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 GlaxoSmithKline Mental Disorders Drugs Products Offered
12.4.5 GlaxoSmithKline Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Corporation Information
12.5.2 AstraZeneca Business Overview
12.5.3 AstraZeneca Mental Disorders Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 AstraZeneca Mental Disorders Drugs Products Offered
12.5.5 AstraZeneca Recent Development
12.6 Bristol-Myers Squibb
12.6.1 Bristol-Myers Squibb Corporation Information
12.6.2 Bristol-Myers Squibb Business Overview
12.6.3 Bristol-Myers Squibb Mental Disorders Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Bristol-Myers Squibb Mental Disorders Drugs Products Offered
12.6.5 Bristol-Myers Squibb Recent Development
12.7 Abbott Laboratories
12.7.1 Abbott Laboratories Corporation Information
12.7.2 Abbott Laboratories Business Overview
12.7.3 Abbott Laboratories Mental Disorders Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Abbott Laboratories Mental Disorders Drugs Products Offered
12.7.5 Abbott Laboratories Recent Development
...

13 Mental Disorders Drugs Manufacturing Cost Analysis
13.1 Mental Disorders Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Mental Disorders Drugs
13.4 Mental Disorders Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Mental Disorders Drugs Distributors List
14.3 Mental Disorders Drugs Customers

15 Market Dynamics
15.1 Mental Disorders Drugs Market Trends
15.2 Mental Disorders Drugs Drivers
15.3 Mental Disorders Drugs Market Challenges
15.4 Mental Disorders Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Mental Disorders Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Mental Disorders Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Mental Disorders Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Mental Disorders Drugs Sales (K Units) by Region (2016-2021)
Table 5. Global Mental Disorders Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Mental Disorders Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Mental Disorders Drugs Revenue Share by Region (2016-2021)
Table 8. Global Mental Disorders Drugs Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Mental Disorders Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Mental Disorders Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Mental Disorders Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Mental Disorders Drugs Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Mental Disorders Drugs Sales Share by Company (2016-2021)
Table 14. Global Mental Disorders Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Mental Disorders Drugs Revenue Share by Company (2016-2021)
Table 16. Global Mental Disorders Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mental Disorders Drugs as of 2020)
Table 17. Global Mental Disorders Drugs Average Price (USD/Pcs) of Key Company (2016-2021)
Table 18. Manufacturers Mental Disorders Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Mental Disorders Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Mental Disorders Drugs Sales (K Units) by Type (2016-2021)
Table 22. Global Mental Disorders Drugs Sales Share by Type (2016-2021)
Table 23. Global Mental Disorders Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Mental Disorders Drugs Price (USD/Pcs) by Type (2016-2021)
Table 25. Global Mental Disorders Drugs Sales Share by Type (2022-2027)
Table 26. Global Mental Disorders Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Mental Disorders Drugs Revenue Share by Type (2022-2027)
Table 28. Global Mental Disorders Drugs Price (USD/Pcs) by Type (2022-2027)
Table 29. Global Mental Disorders Drugs Sales (K Units) by Application (2016-2021)
Table 30. Global Mental Disorders Drugs Sales Share by Application (2016-2021)
Table 31. Global Mental Disorders Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Mental Disorders Drugs Price (USD/Pcs) by Application (2016-2021)
Table 33. Global Mental Disorders Drugs Sales (K Units) by Application (2022-2027)
Table 34. Global Mental Disorders Drugs Sales Share by Application (2022-2027)
Table 35. Global Mental Disorders Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Mental Disorders Drugs Revenue Share by Application (2022-2027)
Table 37. Global Mental Disorders Drugs Price (USD/Pcs) by Application (2022-2027)
Table 38. North America Mental Disorders Drugs Sales (K Units) by Company (2016-2021)
Table 39. North America Mental Disorders Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Mental Disorders Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Mental Disorders Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Mental Disorders Drugs Sales by Type (2016-2021) & (K Units)
Table 43. North America Mental Disorders Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Mental Disorders Drugs Sales by Type (2022-2027) & (K Units)
Table 45. North America Mental Disorders Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Mental Disorders Drugs Sales by Application (2016-2021) & (K Units)
Table 47. North America Mental Disorders Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Mental Disorders Drugs Sales by Application (2022-2027) & (K Units)
Table 49. North America Mental Disorders Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Mental Disorders Drugs Sales (K Units) by Company (2016-2021)
Table 51. Europe Mental Disorders Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Mental Disorders Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Mental Disorders Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Mental Disorders Drugs Sales by Type (2016-2021) & (K Units)
Table 55. Europe Mental Disorders Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Mental Disorders Drugs Sales by Type (2022-2027) & (K Units)
Table 57. Europe Mental Disorders Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Mental Disorders Drugs Sales by Application (2016-2021) & (K Units)
Table 59. Europe Mental Disorders Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Mental Disorders Drugs Sales by Application (2022-2027) & (K Units)
Table 61. Europe Mental Disorders Drugs Sales Market Share by Application (2022-2027)
Table 62. China Mental Disorders Drugs Sales (K Units) by Company (2016-2021)
Table 63. China Mental Disorders Drugs Sales Market Share by Company (2016-2021)
Table 64. China Mental Disorders Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Mental Disorders Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Mental Disorders Drugs Sales by Type (2016-2021) & (K Units)
Table 67. China Mental Disorders Drugs Sales Market Share by Type (2016-2021)
Table 68. China Mental Disorders Drugs Sales by Type (2022-2027) & (K Units)
Table 69. China Mental Disorders Drugs Sales Market Share by Type (2022-2027)
Table 70. China Mental Disorders Drugs Sales by Application (2016-2021) & (K Units)
Table 71. China Mental Disorders Drugs Sales Market Share by Application (2016-2021)
Table 72. China Mental Disorders Drugs Sales by Application (2022-2027) & (K Units)
Table 73. China Mental Disorders Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Mental Disorders Drugs Sales (K Units) by Company (2016-2021)
Table 75. Japan Mental Disorders Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Mental Disorders Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Mental Disorders Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Mental Disorders Drugs Sales by Type (2016-2021) & (K Units)
Table 79. Japan Mental Disorders Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Mental Disorders Drugs Sales by Type (2022-2027) & (K Units)
Table 81. Japan Mental Disorders Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Mental Disorders Drugs Sales by Application (2016-2021) & (K Units)
Table 83. Japan Mental Disorders Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Mental Disorders Drugs Sales by Application (2022-2027) & (K Units)
Table 85. Japan Mental Disorders Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Mental Disorders Drugs Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Mental Disorders Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Mental Disorders Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Mental Disorders Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Mental Disorders Drugs Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Mental Disorders Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Mental Disorders Drugs Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Mental Disorders Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Mental Disorders Drugs Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Mental Disorders Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Mental Disorders Drugs Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Mental Disorders Drugs Sales Market Share by Application (2022-2027)
Table 98. India Mental Disorders Drugs Sales (K Units) by Company (2016-2021)
Table 99. India Mental Disorders Drugs Sales Market Share by Company (2016-2021)
Table 100. India Mental Disorders Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Mental Disorders Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Mental Disorders Drugs Sales by Type (2016-2021) & (K Units)
Table 103. India Mental Disorders Drugs Sales Market Share by Type (2016-2021)
Table 104. India Mental Disorders Drugs Sales by Type (2022-2027) & (K Units)
Table 105. India Mental Disorders Drugs Sales Market Share by Type (2022-2027)
Table 106. India Mental Disorders Drugs Sales by Application (2016-2021) & (K Units)
Table 107. India Mental Disorders Drugs Sales Market Share by Application (2016-2021)
Table 108. India Mental Disorders Drugs Sales by Application (2022-2027) & (K Units)
Table 109. India Mental Disorders Drugs Sales Market Share by Application (2022-2027)
Table 110. Johnson & Johnson Corporation Information
Table 111. Johnson & Johnson Description and Business Overview
Table 112. Johnson & Johnson Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 113. Johnson & Johnson Mental Disorders Drugs Product
Table 114. Johnson & Johnson Recent Development
Table 115. Pfizer Corporation Information
Table 116. Pfizer Description and Business Overview
Table 117. Pfizer Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 118. Pfizer Mental Disorders Drugs Product
Table 119. Pfizer Recent Development
Table 120. Eli Lilly Corporation Information
Table 121. Eli Lilly Description and Business Overview
Table 122. Eli Lilly Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 123. Eli Lilly Mental Disorders Drugs Product
Table 124. Eli Lilly Recent Development
Table 125. GlaxoSmithKline Corporation Information
Table 126. GlaxoSmithKline Description and Business Overview
Table 127. GlaxoSmithKline Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 128. GlaxoSmithKline Mental Disorders Drugs Product
Table 129. GlaxoSmithKline Recent Development
Table 130. AstraZeneca Corporation Information
Table 131. AstraZeneca Description and Business Overview
Table 132. AstraZeneca Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 133. AstraZeneca Mental Disorders Drugs Product
Table 134. AstraZeneca Recent Development
Table 135. Bristol-Myers Squibb Corporation Information
Table 136. Bristol-Myers Squibb Description and Business Overview
Table 137. Bristol-Myers Squibb Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 138. Bristol-Myers Squibb Mental Disorders Drugs Product
Table 139. Bristol-Myers Squibb Recent Development
Table 140. Abbott Laboratories Corporation Information
Table 141. Abbott Laboratories Description and Business Overview
Table 142. Abbott Laboratories Mental Disorders Drugs Sales (K Units), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 143. Abbott Laboratories Mental Disorders Drugs Product
Table 144. Abbott Laboratories Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Mental Disorders Drugs Distributors List
Table 148. Mental Disorders Drugs Customers List
Table 149. Mental Disorders Drugs Market Trends
Table 150. Mental Disorders Drugs Market Drivers
Table 151. Mental Disorders Drugs Market Challenges
Table 152. Mental Disorders Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Mental Disorders Drugs Product Picture
Figure 2. Global Mental Disorders Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Drugs for Schizophrenia Product Picture
Figure 4. Antidepressants Product Picture
Figure 5. Antipsychotics Product Picture
Figure 6. Anxiolytics Product Picture
Figure 7. Drugs for the Treatment of Substance and Alcohol Addiction Product Picture
Figure 8. Drugs for Childhood and Adolescent Mental Illness Product Picture
Figure 9. Drugs to Treat Cognitive Disorders Product Picture
Figure 10. Sleep Disorders Product Picture
Figure 11. Others Product Picture
Figure 12. Global Mental Disorders Drugs Sales Market Share by Application in 2021 & 2027
Figure 13. Children Examples
Figure 14. Adolescents Examples
Figure 15. Adults Examples
Figure 16. Global Mental Disorders Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Mental Disorders Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 18. Global Mental Disorders Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 19. Global Mental Disorders Drugs Price Trends Growth Rate (2016-2027) (USD/Pcs)
Figure 20. Global Mental Disorders Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 21. Global Mental Disorders Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 22. North America Mental Disorders Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. North America Mental Disorders Drugs Sales (K Units) Growth Rate (2016-2027)
Figure 24. Europe Mental Disorders Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Europe Mental Disorders Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. China Mental Disorders Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. China Mental Disorders Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 28. Japan Mental Disorders Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 29. Japan Mental Disorders Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 30. Southeast Asia Mental Disorders Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 31. Southeast Asia Mental Disorders Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 32. India Mental Disorders Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 33. India Mental Disorders Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 34. Global 5 Largest Mental Disorders Drugs Players Market Share by Revenue in Mental Disorders Drugs: 2016 & 2020
Figure 35. Mental Disorders Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 36. Global Mental Disorders Drugs Revenue Share by Type (2016-2021)
Figure 37. Global Mental Disorders Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 38. Global Mental Disorders Drugs Revenue Share by Application (2016-2021)
Figure 39. Global Mental Disorders Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 40. North America Mental Disorders Drugs Sales Market Share by Type in 2020
Figure 41. North America Mental Disorders Drugs Sales Market Share by Application in 2020
Figure 42. Europe Mental Disorders Drugs Sales Market Share by Type in 2020
Figure 43. Europe Mental Disorders Drugs Sales Market Share by Application in 2020
Figure 44. China Mental Disorders Drugs Sales Market Share by Type in 2020
Figure 45. China Mental Disorders Drugs Sales Market Share by Application in 2020
Figure 46. Japan Mental Disorders Drugs Sales Market Share by Type in 2020
Figure 47. Japan Mental Disorders Drugs Sales Market Share by Application in 2020
Figure 48. Southeast Asia Mental Disorders Drugs Sales Market Share by Type in 2020
Figure 49. Southeast Asia Mental Disorders Drugs Sales Market Share by Application in 2020
Figure 50. India Mental Disorders Drugs Sales Market Share by Type in 2020
Figure 51. India Mental Disorders Drugs Sales Market Share by Application in 2020
Figure 52. Key Raw Materials Price Trend
Figure 53. Manufacturing Cost Structure of Mental Disorders Drugs
Figure 54. Manufacturing Process Analysis of Mental Disorders Drugs
Figure 55. Mental Disorders Drugs Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed